Bo Shen

1.2k total citations
43 papers, 820 citations indexed

About

Bo Shen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Bo Shen has authored 43 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 10 papers in Immunology. Recurrent topics in Bo Shen's work include Cancer Immunotherapy and Biomarkers (19 papers), Ferroptosis and cancer prognosis (6 papers) and Cancer Cells and Metastasis (6 papers). Bo Shen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (19 papers), Ferroptosis and cancer prognosis (6 papers) and Cancer Cells and Metastasis (6 papers). Bo Shen collaborates with scholars based in China, United States and Germany. Bo Shen's co-authors include Jifeng Feng, Wei Zhu, Jian Wu, Feng Jiang, Bing Feng, Yuanyuan Zhao, Wenrong Xu, Yan Zhang, Miaolin Zhu and Geyu Liang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Cell Death and Differentiation.

In The Last Decade

Bo Shen

39 papers receiving 814 citations

Peers

Countries citing papers authored by Bo Shen

Since Specialization

Citations

This map shows the geographic impact of Bo Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Shen more than expected).

Fields of papers citing papers by Bo Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Shen. The network helps show where Bo Shen may publish in the future.

Co-authorship network of co-authors of Bo Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Shen. A scholar is included among the top collaborators of Bo Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Shen. Bo Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The rs7799039 variant in the leptin gene promoter drives insulin resistance through reduced serum leptin levels 2025 ·Frontiers in Endocrinology ·Yongyan Song, Youjin Zhang, Xinyu Liu, Gong Wang, Yuhang Ai, Bo Shen, Jing Li, Chuan He	0
2	ALCAM-CD6 axis suppression: a key determinant of immune-mediated metastasis recurrence in stage III non-small cell lung cancer 2025 ·Journal for ImmunoTherapy of Cancer ·(unknown), Xiaoyue Du, Miaolin Zhu, Chao‐Yuan Huang, (unknown), Ming Li, Bowen Hu, (unknown), Feng Jiang, (unknown), Wei Zhu, Guangchuang Yu, Cong Xu, Bo Shen	0
3	Prognostic value of the C-reactive protein to albumin ratio in patients with stroke: a meta-analysis 2025 ·Scientific Reports ·(unknown), Yongjie Chen, (unknown), Fei-Na Li, Xinyu Yang, Bo Shen, Na Li, (unknown), (unknown), Yu Zhang	2
4	Dissection and Fine-Mapping of Two QTL Controlling Grain Size Linked in a 515.6-kb Region on Chromosome 10 of Rice 2024 ·Plants ·(unknown), (unknown), Zhenhua Zhang, Ye‐Yang Fan, Zhonghua Sheng, Jie‐Yun Zhuang, Bo Shen, Yu‐Jun Zhu	1
5	The efficacy of neoadjuvant immunotherapy and lymphocyte subset predictors in locally advanced esophageal squamous cell carcinoma: A retrospective study 2024 ·Cancer Medicine ·(unknown), (unknown), Xiaoyue Du, (unknown), Bowen Hu, Yihan Zhang, (unknown), Feng Jiang, Xiaomin Lu, Miaolin Zhu, Xinyu Xu, Bo Shen	2
6	The ADRIATIC study: revolutionizing the standard treatment paradigm for concurrent chemoradiotherapy in limited-stage small cell lung cancer 2024 ·SHILAP Revista de lepidopterología ·Banzhou Pan, Bo Shen	0
7	Peripheral blood lymphocytes differentiation patterns in responses / outcomes to immune checkpoint blockade therapies in non-small cell lung cancer: a retrospective study 2023 ·BMC Cancer ·Xiaoyue Du, (unknown), Run Shi, (unknown), (unknown), Yihan Zhang, Banzhou Pan, (unknown), Wei Zhu, Jifeng Feng, Xin Wang, Bo Shen	8
8	Gastric cancer derived mesenchymal stem cells promoted DNA repair and cisplatin resistance through up-regulating PD-L1/Rad51 in gastric cancer 2023 ·Cellular Signalling ·Qianqian Wang, Chao‐Yuan Huang, Deqiang Wang, (unknown), (unknown), Yuanyuan Zhao, Mei Wang, Chenglin Zhou, Juan Xu, Bo Shen, Wei Zhu	19
9	Therapeutic effectiveness of anlotinib combined with etoposide in extensive-stage small-cell lung cancer: a single-arm, phase II trial 2023 ·Investigational New Drugs ·Yuan Wu, Xuefeng Zhou, Weiqing Zhao, Qiong Wang, Zhengxiang Han, Lifeng Wang, Wenjie Zhou, Tong Zhou, Haizhu Song, Yong Chen, (unknown), Lin Shi, Banzhou Pan, (unknown), Guoren Zhou, (unknown), Jifeng Feng, Bo Shen	2
10	Combination of Tertiary Lymphoid Structure and Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients With Hepatocellular Carcinoma 2022 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), Chupeng Hu, Xiaoyue Du, (unknown), Xin Wang, Wei Zhu, Qingbo Wang, Miaolin Zhu, Yun Chen, Bo Shen	35
11	Associations of HER2 Mutation With Immune-Related Features and Immunotherapy Outcomes in Solid Tumors 2022 ·Frontiers in Immunology ·Deqiang Wang, Xiaofeng Chen, Yian Du, Xiaoqin Li, (unknown), Yi Lü, Bo Shen, Xuan Gao, Xin Yi, Xuefeng Xia, Xinbing Sui, Yongqian Shu	13
12	Association between changes in thioredoxin reductase and other peripheral blood biomarkers with response to PD-1 inhibitor-based combination immunotherapy in non-small cell lung cancer: a retrospective study 2022 ·Translational Lung Cancer Research ·(unknown), Xiaoyue Du, Yuzhong Chen, (unknown), (unknown), Miaolin Zhu, Weiwei Peng, Gianluca Spitaleri, Paul Hofman, Paolo Bironzo, Xin Wang, Bo Shen	10
13	Topological Abnormalities of Pallido-Thalamo-Cortical Circuit in Functional Brain Network of Patients With Nonchemotherapy With Non-small Cell Lung Cancer 2022 ·Frontiers in Neurology ·Siwen Liu, (unknown), Chenchen Li, (unknown), Jie Ni, Xuan Pan, Rong Ma, Jian Wu, Jifeng Feng, Bo Shen	6
14	MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF 2021 ·Cell Death and Differentiation ·Xin Wang, Uris Ros, (unknown), (unknown), Julia Slotta‐Huspenina, Veronika Dill, Bo Shen, Run Shi, Tobias Herold, Claus Belka, Ritu Mishra, Florian Bassermann, Ana J. García‐Sáez, Philipp J. Jost	12
15	Association of Dynamic Changes in Peripheral Blood Indexes With Response to PD-1 Inhibitor-Based Combination Therapy and Survival Among Patients With Advanced Non-Small Cell Lung Cancer 2021 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), Xiaoyue Du, Yuan Wu, Banzhou Pan, Wei Zhu, Bo Shen	32
16	Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia 2021 ·Gastric Cancer ·Deqiang Wang, Ning Wang, Xiaoqin Li, Xiaofeng Chen, Bo Shen, Dongqin Zhu, Liuqing Zhu, Yaping Xu, Yangyang Yu, Yongqian Shu	26
17	Clinical application of the AUC-guided dosage adjustment of docetaxel-based chemotherapy for patients with solid tumours: a single centre, prospective and randomised control study 2020 ·Journal of Translational Medicine ·Ning Sun, Bo Shen, Jiali Zhu, Xiaomei Zhang, (unknown), Geyu Liang, (unknown), Jianwei Lu, Yan Zhang	7
18	Comprehensive analysis of prognostic immune‐related genes in the tumor microenvironment of cutaneous melanoma 2019 ·Journal of Cellular Physiology ·Sheng Yang, Tong Liu, Hongmei Nan, Yan Wang, Hao Chen, Xiaomei Zhang, Yan Zhang, Bo Shen, (unknown), Siyi Xu, Jing Sui, Geyu Liang	81
19	ADAM33 gene polymorphisms identified to be associated with asthma in a Chinese Li population 2017 ·Biomedical Reports ·Bo Shen, Rong Lin, (unknown), (unknown), Yan Sun, Yong‐Le Yang, Yingying Lin	10
20	Clinical Research on Albumin-Bound Paclitaxel-Based Chemotherapy for Advanced Esophageal Cancer 2015 ·Asian Pacific Journal of Cancer Prevention ·Yuan Yuan, (unknown), Lin Shi, (unknown), (unknown), Bo Shen	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact